ARTEMIO
MOJON OJEA
PROFESOR/A TITULAR DE UNIVERSIDAD TC
University of Texas at Austin
Austin, Estados UnidosPublicacións en colaboración con investigadores/as de University of Texas at Austin (29)
2024
-
Impact of hypertension treatment-time on cardiovascular outcomes: erroneous trial selection leading to suspect findings
Journal of hypertension, Vol. 42, Núm. 1, pp. 190-191
2023
-
Critical appraisal of recent translational chronopharmacology and chronotherapeutic reviews, meta-analyses, and pragmatic patient trials discloses significant deficiencies of design and conduct and suspect findings
Chronobiology International, Vol. 40, Núm. 8, pp. 1146-1167
-
Elevated asleep blood pressure and non-dipper 24h patterning best predict risk for heart failure that can be averted by bedtime hypertension chronotherapy: A review of the published literature
Chronobiology International, Vol. 40, Núm. 1, pp. 63-82
2022
-
Consideration of nondipping heart rate during ambulatory blood pressure monitoring to improve cardiovascular risk assessment. Response
Revista Espanola de Cardiologia
-
Ingestion-time differences in the pharmacodynamics of dual-combination hypertension therapies: Systematic review and meta-analysis of published human trials
Chronobiology International, Vol. 39, Núm. 4, pp. 493-512
2021
-
Ambulatory blood pressure monitoring-based definition of true arterial hypertension
Minerva Medica, Vol. 111, Núm. 6, pp. 573-588
-
Cardiovascular disease risk stratification by the Framigham score is markedly improved by ambulatory compared with office blood pressure
Revista Espanola de Cardiologia, Vol. 74, Núm. 11, pp. 953-961
-
Extent of asleep blood pressure reduction by hypertension medications is ingestion-time dependent: Systematic review and meta-analysis of published human trials
Sleep Medicine Reviews, Vol. 59
-
Guidelines for the design and conduct of human clinical trials on ingestion-time differences–chronopharmacology and chronotherapy–of hypertension medications
Chronobiology International, Vol. 38, Núm. 1, pp. 1-26
-
Ingestion-time differences in the pharmacodynamics of hypertension medications: Systematic review of human chronopharmacology trials
Advanced Drug Delivery Reviews, Vol. 170, pp. 200-213
-
Lowering Nighttime Blood Pressure With Bedtime Dosing of Antihypertensive Medications: Controversies in Hypertension - Pro Side of the Argument
Hypertension, Vol. 78, Núm. 3, pp. 879-893
-
Systematic review and quality evaluation of published human ingestion-time trials of blood pressure-lowering medications and their combinations
Chronobiology International, Vol. 38, Núm. 10, pp. 1460-1476
2020
-
Does Timing of Antihypertensive Medication Dosing Matter?
Current Cardiology Reports, Vol. 22, Núm. 10
-
Ingestion-time–relative to circadian rhythms–differences in the pharmacokinetics and pharmacodynamics of hypertension medications
Expert Opinion on Drug Metabolism and Toxicology, Vol. 16, Núm. 12, pp. 1159-1173
-
New perspectives on the definition, diagnosis, and treatment of true arterial hypertension
Expert Opinion on Pharmacotherapy, Vol. 21, Núm. 10, pp. 1167-1178
2019
-
Diagnosis and management of hypertension: around-the-clock ambulatory blood pressure monitoring is substantially more effective and less costly than daytime office blood pressure measurements
Chronobiology International, Vol. 36, Núm. 11, pp. 1515-1527
2018
-
Hypertension: New perspective on its definition and clinical management by bedtime therapy substantially reduces cardiovascular disease risk
European Journal of Clinical Investigation, Vol. 48, Núm. 5
2017
-
Bedtime Blood Pressure Chronotherapy Significantly Improves Hypertension Management
Heart Failure Clinics, Vol. 13, Núm. 4, pp. 759-773
-
Bedtime Chronotherapy with Conventional Hypertension Medications to Target Increased Asleep Blood Pressure Results in Markedly Better Chronoprevention of Cardiovascular and Other Risks than Customary On-awakening Therapy
Heart Failure Clinics, Vol. 13, Núm. 4, pp. 775-792
2016
-
Chronotherapy with conventional blood pressure medications improves management of hypertension and reduces cardiovascular and stroke risks
Hypertension Research, Vol. 39, Núm. 5, pp. 277-292